Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

248.01 +4.54 (+1.86%)

Streaming Delayed Price Updated: 1:56 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

2 Reasons I'd Happily Hold Johnson & Johnson Through Any Market Crash ↗

Today 6:26 EST

The company has proven its resilience in the past.

Via The Motley Fool

Argenx (ARGX) 2026 Feature: The Anatomy of a Biotech Powerhouse Transitioning to Profitability

February 26, 2026

As of February 26, 2026, the biotechnology sector is witnessing a historic maturation. For years, the industry narrative was dominated by high-burn, pre-revenue innovators searching for a "blockbuster"...

Via Finterra

ACR Alpine Capital Research Buys 1 Million Shares of Arrow Electronics Stock ↗

February 25, 2026

Arrow Electronics is a global distributor delivering electronic components and enterprise IT solutions to industrial and commercial clients.

Via The Motley Fool

Boring Is Beautiful: Why Johnson & Johnson Is Beating the Tech Sector ↗

February 24, 2026

Via MarketBeat

Is Johnson & Johnson Stock Outperforming the Nasdaq?

February 24, 2026

Though Johnson & Johnson has outperformed the broader Nasdaq Composite over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Via Barchart.com

Topics Stocks World Trade

Kenvue Defies Market Headwinds with Q4 Earnings Beat as Kimberly-Clark Merger Looms

February 23, 2026

In a pivotal moment for the consumer health landscape, Kenvue (NYSE: KVUE) has reported a robust set of fourth-quarter results for 2025, signaling a successful turnaround and strategic resilience just...

Via MarketMinute

Topics Earnings Economy World Trade

Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio ↗

February 22, 2026

It's about striking that perfect balance between chasing growth and protecting what you already have.

Via The Motley Fool

Topics Retirement

The Only Healthcare Stock I'd Buy and Never Sell Might Be Johnson & Johnson ↗

February 22, 2026

Johnson & Johnson stock is boring -- in a good way.

Via The Motley Fool

Economic Stagnation: Q4 2025 GDP Misses Mark as Government Shutdown Hangs Heavy Over 2026 Outlook

February 20, 2026

The U.S. economy faced a sobering reality check on Friday as the Bureau of Economic Analysis (BEA) released its preliminary reading for the fourth quarter of 2025. Gross Domestic Product (GDP) grew at...

Via MarketMinute

Topics Earnings Economy

Friday's session: gap up and gap down stock in the S&P500 index ↗

February 20, 2026

Via Chartmill

JNJ Stock Rises As Drugmaker Reportedly Eyes Orthopedics Segment Sale For Up To $20B ↗

February 19, 2026

Bloomberg reported, citing people familiar with the matter, that DePuy Synthes could be valued at more than $20 billion in a sale.

Via Stocktwits

Health Care Sector (XLV) Shows Resilience Amid Tech Volatility and Strong Jobs Data

February 18, 2026

As the broader market grappled with a violent valuation reset in the technology sector, the health care industry emerged as a critical anchor for investors in early 2026. The Health Care Select Sector...

Via MarketMinute

Topics Artificial Intelligence ETFs Earnings

Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania

February 18, 2026

From Johnson & Johnson

Via Business Wire

FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer ↗

February 18, 2026

FDA grants Breakthrough Therapy status to Rybrevant for advanced cancer while Trellus Health extends IBD support contract.

Via Benzinga

Behind the Scenes of Johnson & Johnson's Latest Options Trends ↗

February 17, 2026

Via Benzinga

Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner ↗

February 17, 2026

FDA approves monthly dosing for J&J's Rybrevant Faspro with Lazcluze, offering faster, easier treatment for EGFR lung cancer.

Via Benzinga

The Seven-Thousand Siege: S&P 500’s Historic Breach and the Great Tech Pivot of 2026

February 16, 2026

In a watershed moment for global equity markets, the S&P 500 (INDEXSP:.INX) briefly conquered the psychological 7,000-point milestone in late January 2026, marking the fastest 1,000-point ascent in the...

Via MarketMinute

Topics Artificial Intelligence ETFs Earnings

Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A

February 17, 2026

From BioMedWire

Via GlobeNewswire

ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards

February 16, 2026

As the oncology community prepares to descend upon San Francisco for the 2026 ASCO Genitourinary (GU) Cancers Symposium from February 26–28, investors and clinicians alike are bracing for data that...

Via MarketMinute

Topics Intellectual Property

Jury: Johnson & Johnson Liabile in Case Linking Baby Powder to Cancer ↗

February 14, 2026

On Friday, a Pennsylvania state-court jury in Philadelphia ordered Johnson & Johnson (NYSE: JNJ) to pay $250,000 to the family of Gayle Emerson, finding the company liable in a case blaming its talc...

Via Benzinga

Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial

February 13, 2026

From Beasley Allen Law Firm

Via Business Wire

Volatility Returns to Wall Street: VIX Surges 18% as AI Fatigue Triggers Massive Three-Day Sector Rotation

February 13, 2026

The U.S. equity markets faced a grueling three-session losing streak ending Friday, February 13, 2026, as a wave of "AI capex fatigue" and disappointing corporate guidance sent investors scurrying for...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

"Blowout" Jobs Report Ignites 2026 Growth Hopes as Unemployment Hits 4.3% Floor

February 13, 2026

The U.S. labor market kicked off 2026 with an unexpected surge, as the January nonfarm payrolls report shattered analyst expectations and provided a much-needed jolt to the economic outlook. Adding...

Via MarketMinute

Topics Artificial Intelligence Economy Workforce

The Great Rebound: US M&A Market Ignites as Megadeals Surge 111% in AI-Driven Supercycle

February 12, 2026

The United States merger and acquisition (M&A) landscape has entered a transformative era in early 2026, marking a definitive end to the deal-making drought that plagued the previous two years. Driven...

Via MarketMinute

Topics Artificial Intelligence Economy Energy

Is Johnson & Johnson a Buy, Sell, or Hold in 2026? ↗

February 10, 2026

This reliable dividend payer may be just what the doctor ordered.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property Lawsuit

Novel Serotonergic Agonists Positioned to Capture Share of $150B+ Neuropsychiatric Market

February 10, 2026

EQNX::TICKER_START (NASDAQ:HELP),(NYSE:JNJ),(NYSE:ABBV),(NYSE:TAK),(NYSE:AZN) EQNX::TICKER_END

Via FinancialNewsMedia

Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference

February 09, 2026

From Johnson & Johnson

Via Business Wire

5 Stocks and ETFs to Help Shield Your Portfolio During Volatility ↗

February 09, 2026

Via MarketBeat

Topics ETFs

Johnson & Johnson Reports 90% AFib Freedom In Early Heart Device Study ↗

February 09, 2026

Johnson & Johnson shared early AFib study results showing 90% success and no safety issues, but the stock lagged as healthcare stocks outperformed broader markets.

Via Benzinga

What is Considered a Good Stock Dividend? 2 Healthcare Stocks That Fit the Bill. ↗

February 08, 2026

These companies pay very healthy dividends.

Via The Motley Fool

Topics Bonds

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.